35 Risk of Breast Cancer Recurrence and Contralateral Breast Cancer in Relation to Brca1 and Brca2 Mutation Status Following Breast-Conserving Surgery and Radiotherapy
Powell, S.N.
Breast Diseases A Year Book Quarterly 17(3): 223-225
2006
DOI: 10.1016/s1043-321x(06)80482-0
Accession: 067141717
PDF emailed within 0-6 h: $19.90
Related References
Kirova, Y.M.; Stoppalyonnet, D.; Savignoni, A.; Sigalzafrani, B.; Fabre, N.; Fourquet, A.; I C B, C.S.G. 2005: Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy European Journal of Cancer (1990) 41(15): 2304-2311Kirova, Y.M.; Stoppa-Lyonnet, D.; Savignoni, A.; Sigal-Zafrani, B.; Fabre, N.; Fourquet, A. 2005: Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy European Journal of Cancer 41(15): 2304-2311
Nara, M.; Ishihara, S.; Kitano, A.; Tamura, N.; Aruga, T.; Kobayashi, D.; Nakamura, S.; Yamauchi, H. 2022: Does breast-conserving surgery with radioTherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? a systematic review and meta-analysis Breast Cancer 29(3): 394-401
Kirova, Y.M.; Stoppa Lyonnet, D.; Savignoni, A.; Sigal Zafrani, B.; Clough, K.B.; Barbier, N.; Fourquet, A. 2004: Risk of breast recurrence in relation to BRCA1/2 mutation status following breast-conserving surgery and radiotherapy EJC Suppls 2(3): 150-151
Lin, P.-H.; Chen, S.-C.; Tseng, L.-M.; Chang, K.-J.; Huang, A.-C.; Cheng, K.-C.; Yang, K.; Wu, H.-C.; Chao, T.-Y.; Chang, Y.-C.; Lin, P.-C.; Kuo, W.-H.; Kuo, W.-L.; Lin, C.-H.; Chen, H.-M.; Yeh, D.-C.; Liu, L.-C.; Liu, C.-Y.; Wang, M.-Y.; Lo, C.; Lu, Y.-S.; Huang, C.-S. 2022: Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients Breast Cancer Research and Treatment 192(3): 629-637
Pierce, L.; Levin, A.; Rebbeck, T.; Kardia, S.; Bendavid, M.; Harris, E.; Solin, L.; Haffty, B.; Wynen, E.; Gaffney, D.; Narod, S.; Metcalfe, K.; Dawson, L.; Eisen, A.; Whelan, T.; Olivotto, I.; Galinsky, D.; Meirovitz, A.; Olopade, O.; Garber, J.; Nixon, A.; Merajver, S.; Isaacs, C. 2003: Ten-year outcome of breast-conserving surgery and radiotherapy in women with breast cancer and germline BRCA 1/2 mutations Results from an international collaboration Breast Cancer Research and Treatment 82(Suppl 1): S7
Lee, C.Khoon.; Scott, C.; Lindeman, G.J.; Hamilton, A.; Lieschke, E.; Gibbs, E.; Asher, R.; Badger, H.; Paterson, R.; Macnab, L.; Kwan, E.Michael.; Francis, P.A.; Boyle, F.; Friedlander, M. 2019: Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer British Journal of Cancer 120(3): 279-285
Seynaeve, C.; Meijers Heijboer, H.; Menke, M.; Van Putten, W.; Bartels, C.; Van Den Ouweland, A.; Van Geel, B.; Klijn, J.; Crepin, E.; Kliffen, M.; Brekelmans, C. 2003: Prophylactic mastectomy prevents contralateral breast cancer , without positive impact on survival in BRCA mutation carriers with a previous history of unilateral breast cancer Breast Cancer Research and Treatment 82(Suppl 1): S179
Evron, E.; Ben-David, A.M.; Goldberg, H.; Fried, G.; Kaufman, B.; Catane, R.; Pfeffer, M.R.; Geffen, D.B.; Chernobelsky, P.; Karni, T.; Abdah-Bortnyak, R.; Rosengarten, O.; Matceyevsky, D.; Inbar, M.; Kuten, A.; Corn, B.W. 2019: Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer Annals of Oncology: Official Journal of the European Society for Medical Oncology 30(3): 412-417
Green, L.; Meric-Bernstam, F. 2011: Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer Current Breast Cancer Reports 3(3): 151-155
Cao, W.; Xie, Y.; He, Y.; Li, J.; Wang, T.; Fan, Z.; Fan, T.; Ouyang, T. 2019: Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China Breast Cancer Research and Treatment 175(3): 749-754
Katki, H.A.; Gail, M.H.; Greene, M.H. 2007: Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families Lancet. Oncology 8(12): 1042-1043
Qian, C.; Liang, Y.; Yang, M.; Bao, S.-N.; Bai, J.-L.; Yin, Y.-M.; Yu, H. 2021: Effect of breast-conserving surgery plus radiotherapy versus mastectomy on breast cancer-specific survival for early-stage contralateral breast cancer Gland Surgery 10(10): 2978-2996
Chung, M.A.; Cady, B. 2004: Surgical treatment planning in newly diagnosed breast cancer patients at high risk for BRCA-1 or BRCA-2 mutation Breast Journal 10(6): 473-474
Daniele, A.; Divella, R.; Pilato, B.; Tommasi, S.; Pasanisi, P.; Patruno, M.; Digennaro, M.; Minoia, C.; Dellino, M.; Pisconti, S.; Casamassima, P.; Savino, E.; Paradiso, A.V. 2021: Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? a Mini review Hereditary Cancer in Clinical Practice 19(1): 45